多系统畸形胎儿外显子组测序的诊断率:系统综述与荟萃分析
该系统综述与荟萃分析纳入17项观察性研究、694例多系统畸形胎儿,评估外显子组测序(ES)在染色体微阵列分析(CMA)或核型分析阴性后的增量诊断率。总体诊断率为33%(95%CI 27-40%),单独测序为30%(95%CI 11-52%),三联测序为35%(95%CI 26-44%)。
要点
- 多系统畸形胎儿CMA或核型阴性后,ES可额外检出约三分之一的致病或可能致病变异。
- 单独测序与三联测序的诊断率无显著差异(30% vs 35%)。
- 纳入研究为观察性研究,每组至少5例合格胎儿。
核心结论
- 在多系统结构畸形胎儿中,当CMA或核型分析未能发现病因时,ES可在额外三分之一的病例中识别出可能致病的基因。
- 单独测序与三联测序方法之间未观察到差异。
研究设计与样本
- 系统综述与荟萃分析,遵循PRISMA指南。
- 检索PubMed、Web of Knowledge和Cochrane数据库,纳入描述ES、全基因组和/或下一代测序的观察性研究,涉及5例及以上合格胎儿。
- 共纳入17篇文章,包括694例多系统畸形个体。
- 合格胎儿需具有至少两个不同解剖系统的重大畸形,且CMA或核型分析结果为阴性。
- 仅考虑分类为可能致病或致病且确定为导致胎儿表型的阳性变异。
主要发现
- 总体在213例胎儿中发现可能致病的致病或可能致病变异,ES增量诊断率为33%(95%CI 27-40%)。
- 单独测序的诊断率为30%(95%CI 11-52%),三联测序的诊断率为35%(95%CI 26-44%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the diagnostic yield of exome sequencing (ES) above that of chromosomal microarray analysis (CMA) or karyotyping in fetuses with multisystem structural anomalies (at least two major anomalies in different anatomical systems). METHOD: This was a systematic review conducted in accordance with PRISMA guidelines. Searching PubMed, Web of Knowledge and Cochrane database, we identified studies describing ES, whole-genome and/or next-generation sequencing in fetuses with multisystem malformations. Included were observational studies involving five or more eligible fetuses. A fetus was eligible for inclusion if it had at least two major anomalies of different anatomical systems and a negative CMA or karyotyping result. Only positive variants classified as likely pathogenic or pathogenic determined to be causative of the fetal phenotype were considered. A negative CMA or karyotype result was treated as the reference standard. The diagnostic yield of the primary outcome was calculated by single-proportion analysis using random-effects modeling. A subgroup analysis was performed to compare the diagnostic yield of the solo approach (fetus alone sequenced) with that of the trio approach (fetus and both parents sequenced). RESULTS: Seventeen articles with data on ES diagnostic yield, including 694 individuals with multisystem malformations, were identified. Overall, a pathogenic or likely pathogenic variant potentially causative of the fetal phenotype was found in 213 fetuses, giving a 33% (95% CI, 27-40%) incremental yield of ES. A stratified analysis showed similar diagnostic yields of ES using the solo approach (30%; 95% CI, 11-52%) and the trio approach (35%; 95% CI, 26-44%). CONCLUSIONS: ES applied in fetuses with multisystem structural anomalies was able to identify a potentially causative gene when CMA or karyotyping had failed to do so in an additional one-third of cases. No differences were observed between the solo and trio approaches for ES. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Pauta M, Martinez-Portilla RJ, Borrell A, et al. Diagnostic yield of exome sequencing in fetuses with multisystem malformations: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2022. PMID: 35041238. doi:10.1002/uog.24862
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。